2023-07-012024-06-302024-06-30falseSC196145EBS EUROPE LIMITED2025-03-27falseiso4217:GBPxbrli:pureSC1961452023-07-01SC1961452024-06-30SC1961452023-07-012024-06-30SC1961452022-07-01SC1961452023-06-30SC1961452022-07-012023-06-30SC196145bus:SmallEntities2023-07-012024-06-30SC196145bus:AuditExempt-NoAccountantsReport2023-07-012024-06-30SC196145bus:FullAccounts2023-07-012024-06-30SC196145bus:PrivateLimitedCompanyLtd2023-07-012024-06-30SC196145core:WithinOneYear2024-06-30SC196145core:AfterOneYear2024-06-30SC196145core:WithinOneYear2023-06-30SC196145core:AfterOneYear2023-06-30SC196145core:ShareCapital2024-06-30SC196145core:SharePremium2024-06-30SC196145core:RevaluationReserve2024-06-30SC196145core:OtherReservesSubtotal2024-06-30SC196145core:RetainedEarningsAccumulatedLosses2024-06-30SC196145core:ShareCapital2023-06-30SC196145core:SharePremium2023-06-30SC196145core:RevaluationReserve2023-06-30SC196145core:OtherReservesSubtotal2023-06-30SC196145core:RetainedEarningsAccumulatedLosses2023-06-30SC196145core:LandBuildings2024-06-30SC196145core:PlantMachinery2024-06-30SC196145core:Vehicles2024-06-30SC196145core:FurnitureFittings2024-06-30SC196145core:OfficeEquipment2024-06-30SC196145core:NetGoodwill2024-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2024-06-30SC196145core:ListedExchangeTraded2024-06-30SC196145core:UnlistedNon-exchangeTraded2024-06-30SC196145core:LandBuildings2023-06-30SC196145core:PlantMachinery2023-06-30SC196145core:Vehicles2023-06-30SC196145core:FurnitureFittings2023-06-30SC196145core:OfficeEquipment2023-06-30SC196145core:NetGoodwill2023-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2023-06-30SC196145core:ListedExchangeTraded2023-06-30SC196145core:UnlistedNon-exchangeTraded2023-06-30SC196145core:LandBuildings2023-07-012024-06-30SC196145core:PlantMachinery2023-07-012024-06-30SC196145core:Vehicles2023-07-012024-06-30SC196145core:FurnitureFittings2023-07-012024-06-30SC196145core:OfficeEquipment2023-07-012024-06-30SC196145core:NetGoodwill2023-07-012024-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-30SC196145core:ListedExchangeTraded2023-07-012024-06-30SC196145core:UnlistedNon-exchangeTraded2023-07-012024-06-30SC196145core:MoreThanFiveYears2023-07-012024-06-30SC196145core:Non-currentFinancialInstruments2024-06-30SC196145core:Non-currentFinancialInstruments2023-06-30SC196145dpl:CostSales2023-07-012024-06-30SC196145dpl:DistributionCosts2023-07-012024-06-30SC196145core:LandBuildings2023-07-012024-06-30SC196145core:PlantMachinery2023-07-012024-06-30SC196145core:Vehicles2023-07-012024-06-30SC196145core:FurnitureFittings2023-07-012024-06-30SC196145core:OfficeEquipment2023-07-012024-06-30SC196145dpl:AdministrativeExpenses2023-07-012024-06-30SC196145core:NetGoodwill2023-07-012024-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-30SC196145dpl:GroupUndertakings2023-07-012024-06-30SC196145dpl:ParticipatingInterests2023-07-012024-06-30SC196145dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-30SC196145core:ListedExchangeTraded2023-07-012024-06-30SC196145dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-30SC196145core:UnlistedNon-exchangeTraded2023-07-012024-06-30SC196145dpl:CostSales2022-07-012023-06-30SC196145dpl:DistributionCosts2022-07-012023-06-30SC196145core:LandBuildings2022-07-012023-06-30SC196145core:PlantMachinery2022-07-012023-06-30SC196145core:Vehicles2022-07-012023-06-30SC196145core:FurnitureFittings2022-07-012023-06-30SC196145core:OfficeEquipment2022-07-012023-06-30SC196145dpl:AdministrativeExpenses2022-07-012023-06-30SC196145core:NetGoodwill2022-07-012023-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-30SC196145dpl:GroupUndertakings2022-07-012023-06-30SC196145dpl:ParticipatingInterests2022-07-012023-06-30SC196145dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-30SC196145core:ListedExchangeTraded2022-07-012023-06-30SC196145dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-30SC196145core:UnlistedNon-exchangeTraded2022-07-012023-06-30SC196145core:NetGoodwill2024-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2024-06-30SC196145core:LandBuildings2024-06-30SC196145core:PlantMachinery2024-06-30SC196145core:Vehicles2024-06-30SC196145core:FurnitureFittings2024-06-30SC196145core:OfficeEquipment2024-06-30SC196145core:AfterOneYear2024-06-30SC196145core:WithinOneYear2024-06-30SC196145core:ListedExchangeTraded2024-06-30SC196145core:UnlistedNon-exchangeTraded2024-06-30SC196145core:ShareCapital2024-06-30SC196145core:SharePremium2024-06-30SC196145core:RevaluationReserve2024-06-30SC196145core:OtherReservesSubtotal2024-06-30SC196145core:RetainedEarningsAccumulatedLosses2024-06-30SC196145core:NetGoodwill2023-06-30SC196145core:IntangibleAssetsOtherThanGoodwill2023-06-30SC196145core:LandBuildings2023-06-30SC196145core:PlantMachinery2023-06-30SC196145core:Vehicles2023-06-30SC196145core:FurnitureFittings2023-06-30SC196145core:OfficeEquipment2023-06-30SC196145core:AfterOneYear2023-06-30SC196145core:WithinOneYear2023-06-30SC196145core:ListedExchangeTraded2023-06-30SC196145core:UnlistedNon-exchangeTraded2023-06-30SC196145core:ShareCapital2023-06-30SC196145core:SharePremium2023-06-30SC196145core:RevaluationReserve2023-06-30SC196145core:OtherReservesSubtotal2023-06-30SC196145core:RetainedEarningsAccumulatedLosses2023-06-30SC196145core:NetGoodwill2022-07-01SC196145core:IntangibleAssetsOtherThanGoodwill2022-07-01SC196145core:LandBuildings2022-07-01SC196145core:PlantMachinery2022-07-01SC196145core:Vehicles2022-07-01SC196145core:FurnitureFittings2022-07-01SC196145core:OfficeEquipment2022-07-01SC196145core:AfterOneYear2022-07-01SC196145core:WithinOneYear2022-07-01SC196145core:ListedExchangeTraded2022-07-01SC196145core:UnlistedNon-exchangeTraded2022-07-01SC196145core:ShareCapital2022-07-01SC196145core:SharePremium2022-07-01SC196145core:RevaluationReserve2022-07-01SC196145core:OtherReservesSubtotal2022-07-01SC196145core:RetainedEarningsAccumulatedLosses2022-07-01SC196145core:AfterOneYear2023-07-012024-06-30SC196145core:WithinOneYear2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-30SC196145core:Non-currentFinancialInstrumentscore:CostValuation2024-06-30SC196145core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-30SC196145core:Non-currentFinancialInstrumentscore:CostValuation2023-06-30SC196145core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-30SC196145core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-30SC196145bus:Director12023-07-012024-06-30SC196145bus:Director22023-07-012024-06-30SC196145core:FurnitureFittingsToolsEquipment2023-06-30SC196145core:FurnitureFittingsToolsEquipment2023-07-012024-06-30SC196145core:FurnitureFittingsToolsEquipment2024-06-30

EBS EUROPE LIMITED

Registered Number
SC196145
(Scotland)

Unaudited Financial Statements for the Year ended
30 June 2024

EBS EUROPE LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Directors

BARLOW, Charles Edward Anthony
SMYLY, Robert Dennis

Company Secretary

BARLOW, Charles Edward Anthony

Registered Address

Cavalry Park Business Centre
Peebles
Peeblesshire
EH45 9BU

Registered Number

SC196145 (Scotland)
EBS EUROPE LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets38,8307,131
Investments4382,395359,986
391,225367,117
Current assets
Stocks549,50034,800
Debtors1,426,9711,589,632
Cash at bank and on hand238,897276,817
1,715,3681,901,249
Creditors amounts falling due within one year6(203,419)(310,756)
Net current assets (liabilities)1,511,9491,590,493
Total assets less current liabilities1,903,1741,957,610
Creditors amounts falling due after one year7(85,875)(135,875)
Net assets1,817,2991,821,735
Capital and reserves
Called up share capital142142
Share premium67,45867,458
Profit and loss account1,749,6991,754,135
Shareholders' funds1,817,2991,821,735
The financial statements were approved and authorised for issue by the Board of Directors on 27 March 2025, and are signed on its behalf by:
BARLOW, Charles Edward Anthony
Director
Registered Company No. SC196145
EBS EUROPE LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period. The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received. Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Impairment of non-financial assets policy
Assets which are not carried at fair value are reviewed for evidence of impairment at each reporting date. Where the asset is showing indicators of impairment, the recoverable amount of the asset, is estimated and then compared to the carrying value in the financial statements. Where the carrying amount is in excess of recoverable amount, an impairment loss is recognised in profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2.Average number of employees

20242023
Average number of employees during the year1719
3.Tangible fixed assets

Vehicles

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 July 239,90035,052194,211239,163
Additions--3,0633,063
At 30 June 249,90035,052197,274242,226
Depreciation and impairment
At 01 July 239,90034,951187,181232,032
Charge for year-1011,2631,364
At 30 June 249,90035,052188,444233,396
Net book value
At 30 June 24--8,8308,830
At 30 June 23-1017,0307,131
4.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 July 23359,986359,986
Revaluations22,40922,409
At 30 June 24382,395382,395
Net book value
At 30 June 24382,395382,395
At 30 June 23359,986359,986

Notes

1Other investments other than loans
5.Stocks

2024

2023

££
Work in progress49,50034,800
Total49,50034,800
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables54,619119,651
Bank borrowings and overdrafts47,45847,458
Taxation and social security51,90267,198
Other creditors14,05435,412
Accrued liabilities and deferred income35,38641,037
Total203,419310,756
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts85,875135,875
Total85,875135,875
8.Secured creditors
The company has granted a floating charge in favour of The Royal Bank of Scotland PLC, secured over all sums due or to become due in respect of all property and undertaking of the company.
9.Financial instruments
Instruments measured at fair value through the profit or loss.
10.Share capital
1,420 Ordinary shares of 10p each
11.Related party transactions
During the year £5,000 (2023: £25,000) was received from Cavalry Park LLP in relation to the loan provided. The amount outstanding at the year end of £595,000 (2023: £600,000) is included in other debtors. The Directors of the company are members of Cavalry Park LLP. Interest has been applied at 1.5% market rate. At the year ended 30 June 2024, The Rugbystore Limited, a company where Anthony Barlow is the Director and controlling shareholder, owed EBS Europe Limited £429,695 (2023: £448,195). Commercial interest has been applied to the loan at 1.5% market rate. Included in the loan are Management Charges provided to Rugbystore Limited of £67,500 and Consultancy Services received from Rugbystore Limited of £36,000.